Breakthrough research offers promise for developing new immune therapies for cancer

FHS
May 10, 2024
3:34 am

Scientists from Trinity College Dublin have made an important breakthrough that offers promise for developing new immune therapies for cancer.

Are AI chatbots more creative than humans? New study reveals surprising results

The study published in Scientific Reports compared human and AI chatbot creativity using the alternate uses task (AUT), finding that AI chatbots generally outperformed humans

September 18, 2023

SNK-396 by Synerk for Lipid Disorders: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

July 1, 2023

Boehringer, Lilly secure EC approval for Jardiance to treat CKD

The trial assessed the effect of empagliflozin on kidney disease progression and cardiovascular mortality risk in 6,609 participants. Credit: Marko Aliaksandr / Shutterstock.com. Boehringer Ingelheim

July 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.